Alicia K. Morgans, MD, MPH, on Metastatic and Nonmetastatic Prostate Cancer: New Findings on Androgen-Deprivation Therapy

Posted: Friday, March 17, 2023

Alicia K. Morgans, MD, MPH, of Dana-Farber Cancer Institute, discusses intermittent vs continuous androgen-deprivation therapy in patients with metastatic as well as nonmetastatic prostate cancer, as well as the links to cardiovascular disease and endocrine or metabolic disorders in these populations.

---